CPhI has announced the winners of the distinguished CPhI Pharma awards.
Awards
The awards were hosted at a dedicated gala dinner in the Fairmont Rey Juan Caros I hotel Barcelona. The awards are dedicated to companies and individuals in the pharma industry, who are utilising new approaches, technologies and strategies.
The awards had a number of record entries and an extra four categories were added, covering: ‘Excellence in Pharma: Drug Delivery Devices’, ‘Excellence in Pharma: Regulatory Procedures and Compliance’, ‘Excellence in Pharma: Analysis, Testing and Quality Control’, and ‘Excellence in Pharma: Corporate Social Responsibility’.
A total of 13 pharma companies were picked out of 100 entries highlighting the companies’ contributions to the industry through developments and innovations and strategies.
Some of the winners include life science company Cambrex, who was recognised its Novel Synthesis of Dronedarone Intermediate in ‘API Development’ category, and leading company in identification and production of active principals derived from plants,Indena Spa, who was recognised for its Madagascar Project, which focused on improving the living conditions of local communities involve in Centella asiatica harvesting.
Other winners include Udit Batra, member of the executive board and CEO of life science business, Merck, who was recognised for his work in leading the acquisition of technology company Sigma-Aldrich.
Merck went on to win three awards during the evening with the Merck Emprove Program winning in the ‘Regulatory Procedures and Compliance’ category.
Andreas Mavrommatis, global marketing director at UBM EMEA, added: “The CPhI Pharma Awards celebrates the entire pharma industry, its unique achievements, key people and technological innovations – it's a celebration of everything that is best in our industry. In the last few years, we have seen an impressive increase in the number of entries, a growing appreciation of the overall value and prestige that winning an Award confers on a company, and, of course, a tremendous increase in the quality of emerging technologies submitted for consideration.
"Feedback from our judges is that they have been simply blown away by the consistent quality of submissions – which makes their job of choosing a winner all the more difficult. On behalf of CPhI Worldwide and UBM EMEA, I would like to commend all of the finalists and offer my warmest congratulations to this year’s worthy winners.”